Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: RESTORE ME -- RCT of Oxaloacetate on Improving Fatigue in ME/CFS [NA]

View source ↗

Summary

A randomized controlled trial evaluating oxaloacetate for fatigue in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxaloacetate (oxaloacetate)

Snippet

Sponsor: Terra Biological LLC | Conditions: Myalgic Encephalomyelitis, Chronic Fatigue Syndrome | NA | Status: COMPLETED